United States · FDA National Drug Code directory
XEMBIFY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13533-810_3d491d8b-7fa0-47e4-bec0-4fe6d944fa25
- Product NDC
- 13533-810
- Form
- SOLUTION
- Composition / generic term
- immune globulin subcutaneous, human-klhw
- Labeler
- GRIFOLS USA, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20190703
- Source listing expiry
- 20261231
Source-listed ingredients
- HUMAN IMMUNOGLOBULIN G — 200 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (13533-810-05) / 5 mL in 1 VIAL (13533-810-06) · 13533-810-05
- 1 VIAL in 1 CARTON (13533-810-10) / 10 mL in 1 VIAL (13533-810-11) · 13533-810-10
- 1 VIAL in 1 CARTON (13533-810-20) / 20 mL in 1 VIAL (13533-810-21) · 13533-810-20
- 1 VIAL in 1 CARTON (13533-810-50) / 50 mL in 1 VIAL (13533-810-51) · 13533-810-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →